Sean Cullen
Director, Licensing and Corporate Strategy Nona Biosciences
Seminars
Wednesday 16th September 2026
Next-Generation Immune Cell Engagers: From T-Cell Bispecifics to Myeloid and mRNA-Delivered Modalities
3:00 pm
- End-to-end antibody solution: Powered by the Harbour Mice® platform for fully human antibodies, Nona Biosciences offers an “Idea-to-Clinic” solution spanning discovery, engineering, and binder optimization
- HBICE® engager platform: Combines this expertise with an off-the-shelf library of TAA and effector arms to deliver transformative bispecific and multispecific immune cell engagers
- Next-generation formats: The small size, flexibility, and modularity of HCAbs enable advanced engagers – biparatopic, mRNA-delivered RiboHBICE®, conditionally active, TCR-mimics (TCRm), and myeloid cell engagers
